Key result
Anti-platelet therapy is not a suitable alternative to oral anticoagulation for patients with atrial fibrillation.
Key points are not available for this paper at this time.
Favors oral anticoagulation over anti-platelet alternatives in atrial fibrillation; Level 5 evidence leaves open randomized confirmation.
No takes yet. Share an insight, caveat, or question.
Apostolakis et al. (2009) studied this question. Anti-platelet therapy is not a suitable alternative to oral anticoagulation for patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: